Technical Analysis for INSP - Inspire Medical Systems, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 186.10 | 0.72% | 1.33 |
INSP closed up 4.95 percent on Wednesday, November 20, 2024, on approximately normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Flat | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.72% | |
200 DMA Resistance | Bearish | 0.72% | |
Multiple of Ten Bearish | Other | 0.72% | |
Gapped Up | Strength | 0.72% | |
Up 3 Days in a Row | Strength | 0.72% | |
Oversold Stochastic | Weakness | 0.72% | |
Lower Bollinger Band Walk | Weakness | 5.71% | |
Oversold Stochastic | Weakness | 5.71% | |
Slingshot Bearish | Bearish Swing Setup | 6.17% | |
Stochastic Buy Signal | Bullish | 6.17% |
Alert | Time |
---|---|
200 DMA Resistance | 44 minutes ago |
Up 1% | 44 minutes ago |
60 Minute Opening Range Breakout | about 1 hour ago |
10 DMA Support | about 2 hours ago |
Rose Above 10 DMA | about 2 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire Medical Systems’ proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Medical Technology FDA Sleep Apnea Sleep Disorders Obstructive Sleep Apnea Neurostimulation Invasive Solutions Neurostimulation Technology Sleep Surgery
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Medical Technology FDA Sleep Apnea Sleep Disorders Obstructive Sleep Apnea Neurostimulation Invasive Solutions Neurostimulation Technology Sleep Surgery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 257.4 |
52 Week Low | 123.0 |
Average Volume | 615,602 |
200-Day Moving Average | 186.58 |
50-Day Moving Average | 200.19 |
20-Day Moving Average | 191.19 |
10-Day Moving Average | 185.38 |
Average True Range | 9.57 |
RSI (14) | 45.05 |
ADX | 18.18 |
+DI | 22.23 |
-DI | 21.64 |
Chandelier Exit (Long, 3 ATRs) | 185.46 |
Chandelier Exit (Short, 3 ATRs) | 198.94 |
Upper Bollinger Bands | 211.90 |
Lower Bollinger Band | 170.47 |
Percent B (%b) | 0.35 |
BandWidth | 21.67 |
MACD Line | -5.87 |
MACD Signal Line | -4.19 |
MACD Histogram | -1.6771 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 199.37 | ||||
Resistance 3 (R3) | 199.99 | 195.75 | 196.93 | ||
Resistance 2 (R2) | 195.75 | 192.04 | 195.44 | 196.12 | |
Resistance 1 (R1) | 190.26 | 189.74 | 188.14 | 189.64 | 195.31 |
Pivot Point | 186.02 | 186.02 | 184.96 | 185.71 | 186.02 |
Support 1 (S1) | 180.53 | 182.31 | 178.41 | 179.91 | 174.23 |
Support 2 (S2) | 176.29 | 180.01 | 175.98 | 173.42 | |
Support 3 (S3) | 170.80 | 176.29 | 172.61 | ||
Support 4 (S4) | 170.18 |